Entecavir versus tenofovir in patients with chronic hepatitis B: Enemies or partners in the prevention of hepatocellular carcinoma

被引：36
|
作者：
Lee, Sung Won [1 ,2 ]
Choi, Jonggi [3 ]
Kim, Seung Up [4 ,5 ]
Lim, Young-Suk [3 ]
机构：
[1] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea
[2] Catholic Univ, Liver Res Ctr, Seoul, South Korea
[3] Univ Ulsan, Liver Ctr, Asan Med Ctr, Dept Gastroenterol,Coll Med, Seoul, South Korea
[4] Yonsei Univ, Inst Gastroenterol, Dept Internal Med, Coll Med, Seoul, South Korea
[5] Severance Hosp, Yonsei Liver Ctr, Seoul, South Korea
来源：
CLINICAL AND MOLECULAR HEPATOLOGY | 2021年 / 27卷 / 03期
关键词：
Entecavir; Tenofovir; Hepatitis B; Carcinoma; Hepatocellular; Efficacy; Outcome; DISOPROXIL FUMARATE; RISK; CIRRHOSIS;
D O I：
10.3350/cmh.2021.0179
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Over the past several decades, entecavir (ETV) and tenofovir disoproxil fumarate (TDF) have remained the first-line antiviral agents in several international guidelines. These two antiviral agents have shown similar short to intermediate-term efficacy, including virologic, biochemical, serologic, and histologic responses. However, huge controversies regarding the antiviral efficacy of ETV and TDF in preventing the development of hepatocellular carcinoma (HCC) still exist. In this review, we summarized recent studies that compared the treatment efficacy of ETV and TDF in terms of HCC development.
引用
收藏
页码：402 / 412
页数：11
相关论文
共 50 条
  • [1] Entecavir versus Tenofovir for the Prevention of Hepatocellular Carcinoma in Treatment-naive Chronic Hepatitis B Patients in Korea
    Choi, HeeKyoung
    Seo, Gi Hyeon
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2021, 36 (14) : 1 - 10
  • [2] Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir
    Papatheodoridis, George V.
    Dalekos, George N.
    Yurdaydin, Cihan
    Buti, Maria
    Goulis, John
    Arends, Pauline
    Sypsa, Vana
    Manolakopoulos, Spilios
    Mangia, Giampaolo
    Gatselis, Nikolaos
    Keskin, Onur
    Savvidou, Savvoula
    Hansen, Bettina E.
    Papaioannou, Christos
    Galanis, Kostantinos
    Idilman, Ramazan
    Colombo, Massimo
    Esteban, Rafael
    Janssen, Harry L. A.
    Lampertico, Pietro
    JOURNAL OF HEPATOLOGY, 2015, 62 (02) : 363 - 370
  • [3] Efficacy of entecavir versus tenofovir in preventing hepatocellular carcinoma in patients with chronic hepatitis B with maintained virologic response
    Na, Ji Eun
    Sinn, Dong Hyun
    Lee, Jeong-Hoon
    Jang, Hee Joon
    Baek, Seon Yeong
    Kim, Kyung A.
    Kang, Won Seok
    Gwak, Geum-Youn
    Paik, Young-Han
    Kim, Yoon Jun
    Choi, Moon Seok
    Yoon, Jung-Hwan
    Lee, Joon Hyeok
    Koh, Kwang Cheol
    Paik, Seung Woon
    JOURNAL OF VIRAL HEPATITIS, 2021, 28 (10) : 1392 - 1399
  • [4] Comparable Incidence of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir
    Shin, Jung Woo
    Jeong, Joonho
    Jung, Seok Won
    Lee, Seung Bum
    Park, Bo Ryung
    Kim, Min-Ju
    Park, Eun Ji
    Park, Neung Hwa
    DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (05) : 1739 - 1750
  • [5] Effectiveness and Safety of Entecavir or Tenofovir in a Spanish Cohort of Chronic Hepatitis B Patients: Validation of the Page-B Score to Predict Hepatocellular Carcinoma
    Riveiro-Barciela, Mar
    Tabernero, David
    Calleja, Jose L.
    Lens, Sabela
    Manzano, Maria L.
    Gea Rodriguez, Francisco
    Crespo, Javier
    Piqueras, Belen
    Pascasio, Juan M.
    Comas, Carmen
    Gutierrez, Maria L.
    Aguirre, Alberto
    Suarez, Emilio
    Garcia-Samaniego, Javier
    Rivero, Miguel
    Acero, Doroteo
    Fernandez-Bermejo, Miguel
    Moreno, Diego
    Sanchez-Pobre, Pilar
    de Cuenca, Beatriz
    Moreno-Palomares, J. J.
    Esteban, Rafael
    Buti, Maria
    DIGESTIVE DISEASES AND SCIENCES, 2017, 62 (03) : 784 - 793
  • [6] Tenofovir Versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis B
    Hsu, Yao-Chun
    Wong, Grace Lai-Hung
    Chen, Chong
    Peng, Cheng-Yuan
    Yeh, Ming-Lun
    Cheung, Ka-Shing
    Toyoda, Hidenori
    Huang, Chung-Feng
    Huy Trinh
    Xie, Qing
    Enomoto, Masaru
    Liu, Li
    Yasuda, Satoshi
    Tanaka, Yasuhito
    Kozuka, Ritsuzo
    Tsai, Pei-Chien
    Huang, Yen-Tsung
    Wong, Christopher
    Huang, Rui
    Jang, Tyng-Yuan
    Hoang, Joseph
    Yang, Hwai-, I
    Li, Jiayi
    Lee, Dong-Hyun
    Takahashi, Hirokazu
    Zhang, Jian Q.
    Ogawa, Eiichi
    Zhao, Changqing
    Liu, Chenghai
    Furusyo, Norihiro
    Eguchi, Yuichiro
    Wong, Clifford
    Wu, Chao
    Kumada, Takashi
    Yuen, Man-Fung
    Yu, Ming-Lung
    Nguyen, Mindie H.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 (02) : 271 - 280
  • [7] Is tenofovir disoproxil fumarate superior to entecavir for prevention of hepatocellular carcinoma in patients with chronic hepatitis B?
    van Velsen, Lisa M.
    Sonneveld, Milan J.
    van Erpecum, Karel J.
    HEPATOBILIARY SURGERY AND NUTRITION, 2023, 12 (06) : 919 - 922
  • [8] Comparison of tenofovir versus entecavir on reducing incidence of hepatocellular carcinoma in chronic hepatitis B patients: A systematic review and meta-analysis
    Gu, Lihu
    Yao, Qigu
    Shen, Zefeng
    He, Ying
    Ng, Derry Minyao
    Yang, Tong
    Chen, Bangsheng
    Chen, Ping
    Mao, Feiyan
    Yu, Qili
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 (09) : 1467 - 1476
  • [9] Evaluation of Histological Response in Chronic Hepatitis B Patients with Tenofovir or Entecavir Therapy
    Cercioglu, Duygu
    Kinikli, Sami
    Cesur, Salih
    Ataman Hatipoglu, Cigdem
    Arslan, Kader
    Gonultas, Mehmet
    MIKROBIYOLOJI BULTENI, 2020, 54 (01): : 95 - 109
  • [10] Comparable Incidence of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir
    Jung Woo Shin
    Joonho Jeong
    Seok Won Jung
    Seung Bum Lee
    Bo Ryung Park
    Min-Ju Kim
    Eun Ji Park
    Neung Hwa Park
    Digestive Diseases and Sciences, 2021, 66 : 1739 - 1750
12345